Nicole Hadas
Net worth: 482 300 $ as of 2024-05-30
Profile
Nicole R.
Hadas is a former President & Secretary at Keryx Biopharmaceuticals, Inc. She also worked as a Senior Corporate Counsel at Genzyme Corp.
from 2001 to 2011.
In 2011, she joined Inspiration Biopharmaceuticals, Inc. as a Senior Vice President & General Counsel.
Ms. Hadas was an Associate at Foley Hoag LLP and later became the Vice President & General Counsel at OvaScience, Inc. From 2013 to 2024, she served as the Secretary, Chief Legal Officer & Senior VP at Akebia Therapeutics, Inc. Ms. Hadas completed her undergraduate studies at the University of Michigan and obtained her graduate degree from Boston College Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-30 | 430,625 ( 0.21% ) | 482 300 $ | 2024-05-30 |
Former positions of Nicole Hadas
| Companies | Position | End |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | General Counsel | 2024-06-13 |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | General Counsel | - |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | General Counsel | 2012-12-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 2010-12-31 |
| KERYX BIOPHARMACEUTICALS | President | - |
Training of Nicole Hadas
| University of Michigan | Undergraduate Degree |
| Boston College Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Foley Hoag LLP
 Foley Hoag LLP Miscellaneous Commercial ServicesCommercial Services Foley Hoag LLP provides legal services. It offers international litigation and arbitration services, and counsel in the evolving field of corporate social responsibility. The firm offers practices in industries such as life sciences, health care, technology, energy and renewable, investment management, and professional services. The company was founded in 1943 and is headquartered in Boston, MA. | Commercial Services |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Nicole Hadas
